NCT04666090 2025-05-15Carrelizumab, Chemotherapy and Apatinib in the Neoadjuvant Treatment of Resectable Esophageal Squamous Cell CarcinomaSecond Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 2 Active not recruiting42 enrolled